7402 Hussain et al.
Asian J. Chem.
diisopropylcarbamate (1 g, 3.41 mmol, 1 eq) (1) and N,N,N,N-
tetramethylethylenediamine (0.61 mL, 4.09 mmol, 1.2 eq) (2a)
in Et2O (17 mL) at -78 °C, sec-BuLi (1.6 M in 92:8 cyclohexane/
hexane, 2.9 mL, 3.75 mmol, 1.1 eq) was added dropwise and
stirred for 5 h at -78 °C. Then allyl boronic acid pinacol ester
(0.77 mL, 4.09 mmol, 1.2 eq) (2) was added dropwise to the
reaction mixture and further stirred at -78 °C for 1 h and warmed
to room temperature. At this stage, a solution of MgBr2·OEt2
in Et2O, made as follows, was added to the reaction mixture.
[At room temperature, 1,2-dibromoethane (0.60 mL, 6.88
mmol, 1 eq) was added into a suspension of magnesium (0.17
g, 6.88 mmol, 1 eq) in Et2O (8.6 mL). The reaction flask was
further stirred for 2 h after placing into a water bath in order to
control the moderate exotherm]. Biphasic mixture having two
layers thus obtained was added to the former reaction mixture
via syringe and then refluxed for 16 h. Reaction mixture was
then cooled to room temperature. Water was used to quench
the reaction. After adding diethyl ether, layers were extracted
and washed with 1 N hydrochloric acid, 1 N sodium hydroxide,
water and then brine. It was dried with MgSO4 and concen-
trated. Column chromatography (SiO2) was then used to purify
the crude product. Pure(R)-2-(1-(4-methoxyphenyl)hex-5-en-
3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3) (0.84 g,
77.60 %) was obtained as colorless oil. The reaction is given
in Fig. 1.
Synthesis and Characterization of (E)-2-[1-(4-methoxy-
phenyl)-6-(phenylsulfonyl)hex-5-en-3-yl]-4,4,5,5-tetra-
methyl-1,3,2-dioxaborolane (5): Grubbs-Hoveyda II (4a) (3.9
mg, 0.0063 mmol, 0.05 eq) was added to a solution of 2-[1-
(4-methoxyphenyl)hex-5-en-3-yl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (3) (40 mg, 0.126 mmol, 1 eq) and (vinyl-
sulfonyl)benzene (4) (0.0635 g, 0.378 mmol, 3 eq) in CH2Cl2
(2 mL). After fitting a condenser to the flask, reaction mixture
was refluxed for 15 h under nitrogen. The reaction mixture
was reduced in volume to 0.5 mL and then purified directly
on a silica gel column eluting with 9:1 Pet. Ether/EtOAc to
get the desired product (E)-2-(1-(4-methoxyphenyl)-6-
(phenylsulfonyl)hex-5-en-3-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (5) as dark brown solid (0.0438 g, 77.25 %)10
m.p. 82 °C (Fig. 2).
O
B
O
O
S
Ph
+
O
(3)
O
(4)
O
O
O
B
O
Grubbs Hoveyda
2nd generation (4a)
40oC, 15h
S
Ph
O
O
N
+
B
O
O
O
(5)
(1)
O
(2)
Fig. 2. Synthesis of (E)-2-(1-(4-methoxyphenyl)-6-(phenylsulfonyl)hex-5-
en-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
O
O
B
1H NMR (400 MHz, CDCl3): δ ppm 7.88-7.84 (2H, m, 2
× ArH) 7.62-7.56 (1H, m, 1 × ArH) 7.54-7.48 (2H, m, 2 ×
ArH) 7.05-6.99 (2H, m, 2 ×ArH) 6.96 (1H, t, J = 6.97 Hz, CH2-
CH=CH) 6.84-6.77 (2H, m, 2 × ArH) 6.31 (1H, dt, J = 15.16,
1.47 Hz, CH2-CH=CH) 3.78 (3H, s, -CH3) 2.59-2.45 (2H, m,
CH2-CH2-CHB) 2.43-2.26 (2H, m, CH2-CHB-CH2) 1.77-1.66
(1H, m, CH2-CHB-CHH) 1.63-1.53 (1H, m, CH2-CHB-CHH)
1.27-1.21 (1H, m, CH2-CHB-CH2) 1.18 (12 H, s, 4 × CH3).
13C NMR (100 MHz, CDCl3): δ ppm 157.7 (1C, ArC-O)
146.9 (1C, ArC-S) 140.8 (1C, CH=CH-S) 134.2 (1C, CH=CH-
S) 133.1 (1C, ArC-CH2) 130.6 (1C, ArCH) 129.2 (2C, 2 ×
ArCH) 129.1 (2C, 2 × ArCH) 127.5 (2C, 2 × ArCH) 113.7
(2C, 2 × ArCH) 83.4 (2C, 2 × C(CH3)2) 55.2 (1C, OCH3) 34.1
(1C, CH2CHBCH2) 33.1 (1C, CH2CH2CHB) 32.8 (4C, 2 ×
(CH3)2C) 24.8 (1C, -CHBCH2CH) 24.7 (1C, CH2CH2CHB).
11B NMR (96.23 MHz, none): δ ppm 33.24, IR (film):
ν(cm-1) 2977, 2924 (sp3 C-H stretch), 1511, 1446 (sp2 C=C
stretch), 1244, 1176, 1141 (sp3C-O stretch), 822, 730, 687
(sp2 C-H oop bending).
s-BuLi
TMEDA
(2a)
Et2O
(3)
O
Fig. 1. Synthesis of 2-(1-(4-methoxyphenyl)hex-5-en-3-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane
1H NMR (400 MHz, CDCl3): δ ppm 7.09 (2H, d, J =
8.80 Hz, 2 × ArH) 6.81 (2H, d, J = 8.80 Hz, 2 × ArH) 5.86-
5.75 (1 H, m, CH=CH2) 5.04 (1H, d, J = 2.20 Hz, CH=CHH)
4.94 (1H, d, J = 10.27 Hz, CH=CHH) 3.78 (3H, s, OCH3)
2.63-2.48 (2H, m, ArCH2CH2CHBCH2) 2.27-2.11 (2H, m,
ArCH2 CH2CHBCH2) 1.78-1.58 (2H, m,ArCH2CH2CHBCH2)
1.25 (12 H, s, 4 × CH3) 1.08-1.18 (1 H, m,ArCH2CH2CHBCH2).
13C NMR (100 MHz, CDCl3): δ ppm 157.6 (1C, -OCH3),
138.4 (2C, 2 ×ArCH), 135 (2C, 2 ×ArCH), 129.2 (1C,ArC-O),
114.9 (1C, -CH2CH=CH2), 113.6 (1C, -CHb=CH2), 83 (2C, 2
× C(CH3)2), 55.2 (1C, ArCCH2), 35.3 (1C, -CH2CH2CHB),
34.5 (1C, -CH2CHB), 33.1 (1C, -CHBCH2CH), 24.9 (1C,
-CH2CH2CHB), 24.8 (4C, 2 × (CH3)2C).
Synthesis and characterization of (E)-1-(hexa-3,5-dien-
1-yl)-4-methoxybenzene (7): To a solution of 3,5-(CF3)2C6H3Br
(24.6 mg, 0.084 mmol, 1.2 eq) in THF (1.9 mL) at -78 °C
n-BuLi (1.6 M in hexanes, 0.053 mL, 0.084 mmol, 1.2 eq)
was dropwise added. Reaction mixture was then stirred for
11B NMR (96.23 MHz, none): δ ppm 33.24, IR (film):
ν(cm-1) 3026 (sp2C-H stretch), 2977, 2924, 2852 (sp3 C-H
stretch), 1511, 1456 (sp2 C=C stretch), 1243, 1175, 1142 (sp3
C-O stretch), 846, 822, 670 (sp2 C-H oop bending).